eMedicine Specialties > Cardiology > Cancer and the Heart

Carney Complex: Differential Diagnoses & Workup

Author: Craig T Basson, MD, PhD, FAHA, FACC, Director, Cardiovascular Research, The New York Presbyterian Hospital; Professor, Greenberg Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University
Coauthor(s): Luke K Kim, MD, Fellow, Department of Internal Medicine, Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical Center; Carl J Vaughan, MD, MRCPI, Adjunct Assistant Professor, Department of Internal Medicine, Division of Cardiology, Weill Medical College of Cornell University; Consulting Cardiologist, Mercy University Hospital, Ireland
Contributor Information and Disclosures

Updated: Mar 18, 2009

Differential Diagnoses

Adrenal Adenoma
Adrenal Carcinoma
Breast Cancer
Cardiac Neoplasms, Primary
Rhabdomyomas

Other Problems to Be Considered

Intracardiac thrombus
Metastatic neoplasm to the heart
Breast adenoma/carcinoma
Testicular adenoma/carcinoma

Workup

Laboratory Studies

  • Complete blood count
  • Glucose/electrolytes
  • Erythrocyte sedimentation rate
  • Thyroxine/thyroid stimulating hormone
  • Adrenocorticotropic hormone
  • Growth hormone

Imaging Studies

 

Transthoracic echocardiogram of a left atrial myx...

Transthoracic echocardiogram of a left atrial myxoma in an individual with Carney complex. A 42-year-old woman with a history of facial spotty pigmentation and cutaneous myxomas presented for annual surveillance echocardiography. Findings from previous echocardiograms were normal. Echocardiography now revealed a 1.0 X 1.3 cm mass (arrow) in the left atrium (LA) arising from the interatrial septum above the mitral valve. No prolapse was seen into the left ventricle (LV). Histopathology upon surgical excision demonstrated that the lesion was a myxoma.

Transthoracic echocardiogram of a left atrial myx...

Transthoracic echocardiogram of a left atrial myxoma in an individual with Carney complex. A 42-year-old woman with a history of facial spotty pigmentation and cutaneous myxomas presented for annual surveillance echocardiography. Findings from previous echocardiograms were normal. Echocardiography now revealed a 1.0 X 1.3 cm mass (arrow) in the left atrium (LA) arising from the interatrial septum above the mitral valve. No prolapse was seen into the left ventricle (LV). Histopathology upon surgical excision demonstrated that the lesion was a myxoma.

  • Echocardiography is the investigation of choice to define cardiac involvement in the Carney complex.6
    • Occasionally, evidence of myxomas may be in more than one cavity.
    • Echocardiography also defines the presence of associated valvular involvement.
    • Left atrial myxomas may prolapse through the mitral valve orifice, creating functional mitral stenosis, or may produce progressive valve leaflet damage, leading to mitral insufficiency.
    • Echocardiography is useful for follow-up of patients after surgical removal of the tumor to detect recurrence of myxomas.
  • Transesophageal echocardiography reaches a sensitivity of 100%. It is useful to define the precise anatomical relationships of small tumors or to detect the presence of multiple cardiac myxomas.
  • Body computed tomography scan or MRI may be appropriate to exclude extracardiac thoracic, abdominal, or paraspinal tumors.
  • Testicular ultrasonography may be used to exclude testicular tumors.

Other Tests

  • ECG: No specific electrocardiographic features of the Carney complex exist. The ECG findings may reflect the presence of left atrial enlargement or pulmonary hypertension.
  • Genetic evaluation7 : Patients thought to have Carney complex should be evaluated by a cardiologist/geneticist with experience in the management of inherited cardiovascular disease.
    • Referral to an endocrinologist may be appropriate if endocrinological problems are suggested by symptoms or laboratory studies
    • The initial step in the workup of these patients is the ascertainment of a detailed family history to establish if the patient's disease represents a new mutation or is part of a familial syndrome. Recent studies have shown that linkage analysis of extended families can provide diagnostic information for individuals with equivocal findings; however, these techniques remain research tools that generally are not available clinically. Furthermore, mutational analysis of the PRKAR1A gene may be a useful adjunctive diagnostic test. In the presence of a family history of arthrogryposis, testing for mutation of MYH8 may be appropriate as well. However, such DNA-based testing currently remains the province of research laboratories (see GeneTests).

Procedures

Cardiac catheterization may be indicated on an individual basis prior to surgical resection if coexisting coronary artery disease is a possibility.

Histologic Findings

Myxomas have a typical histologic appearance of small stellate cells against a bland proteoglycan background.

More on Carney Complex

Overview: Carney Complex
Differential Diagnoses & Workup: Carney Complex
Treatment & Medication: Carney Complex
Follow-up: Carney Complex
Multimedia: Carney Complex
References

References

  1. Basson CT, MacRae CA, Korf B, Merliss A. Genetic heterogeneity of familial atrial myxoma syndromes (Carney complex). Am J Cardiol. Apr 1 1997;79(7):994-5. [Medline].

  2. Stratakis CA, Carney JA, Lin JP, et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. Feb 1 1996;97(3):699-705. [Medline].

  3. Casey M, Mah C, Merliss AD, et al. Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation. Dec 8 1998;98(23):2560-6. [Medline].

  4. Casey M, Vaughan CJ, He J, et al. Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest. Sep 2000;106(5):R31-8. [Medline].

  5. Veugelers M, Bressan M, McDermott DA, Weremowicz S, Morton CC, Mabry CC, et al. Mutation of perinatal myosin heavy chain associated with a Carney complex variant. N Engl J Med. Jul 29 2004;351(5):460-9. [Medline].

  6. Reynen K. Cardiac myxomas. N Engl J Med. Dec 14 1995;333(24):1610-7. [Medline].

  7. Goldstein MM, Casey M, Carney JA, Basson CT. Molecular genetic diagnosis of the familial myxoma syndrome (Carney complex). Am J Med Genet. Sep 3 1999;86(1):62-5. [Medline].

  8. Carney JA, Gordon H, Carpenter PC, et al. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore). Jul 1985;64(4):270-83. [Medline].

  9. Kanda T, Umeyama S, Sasaki A, et al. Interleukin-6 and cardiac myxoma. Am J Cardiol. Nov 1 1994;74(9):965-7. [Medline].

  10. Veugelers M, Wilkes D, Burton K, et al. Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci U S A. Sep 28 2004;101(39):14222-7.

Further Reading

Keywords

carney complex, lentigines, atrial myxomas, mucocutaneous myxomas, blue nevi, LAMB syndrome, nevi, atrial myxoma, myxoid neurofibroma, ephelides, NAME syndrome, rhabdomyoma, myxoma, cardiac myxomas, cardiac tumor, heart tumor, cutaneous myxoma, spotty pigmentation of the skin, endocrinopathy, endocrine tumor, nonendocrine tumor

Contributor Information and Disclosures

Author

Craig T Basson, MD, PhD, FAHA, FACC, Director, Cardiovascular Research, The New York Presbyterian Hospital; Professor, Greenberg Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University
Craig T Basson, MD, PhD, FAHA, FACC is a member of the following medical societies: American College of Cardiology and American Heart Association
Disclosure: Nothing to disclose.

Coauthor(s)

Luke K Kim, MD, Fellow, Department of Internal Medicine, Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical Center
Disclosure: Nothing to disclose.

Carl J Vaughan, MD, MRCPI, Adjunct Assistant Professor, Department of Internal Medicine, Division of Cardiology, Weill Medical College of Cornell University; Consulting Cardiologist, Mercy University Hospital, Ireland
Carl J Vaughan, MD, MRCPI is a member of the following medical societies: American College of Cardiology, American College of Physicians, and American Heart Association
Disclosure: Nothing to disclose.

Medical Editor

Justin D Pearlman, MD, PhD, ME, MA, Director of Advanced Cardiovascular Imaging, Professor of Medicine, Professor of Radiology, Adjunct Professor, Thayer Bioengineering and Computer Science, Dartmouth-Hitchcock Medical Center
Justin D Pearlman, MD, PhD, ME, MA is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Federation for Medical Research, International Society for Magnetic Resonance in Medicine, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Frank M Sheridan, MD, Cardiology, Providence Everett Medical Center
Frank M Sheridan, MD is a member of the following medical societies: American College of Cardiology, American Heart Association, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

CME Editor

Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital
Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

Chief Editor

Richard A Lange, MD, Professor and Executive Vice Chairman of Medicine, University of Texas Health Science Center at San Antonio
Richard A Lange, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, and Association of Subspecialty Professors
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.